It has been suggested that brachyury inhibits the cell cycle by downregulating cyclin D (CCND1), RB (RB1) and CDKN1A (P21), ultimately decreasing the susceptibility of tumor cells to cytotoxic therapies (Huang et al., 2013). The gene discussed is CDKN1A; the disease is neoplasm.